Compare MOV & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOV | HQL |
|---|---|---|
| Founded | 1961 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 490.5M |
| IPO Year | N/A | N/A |
| Metric | MOV | HQL |
|---|---|---|
| Price | $23.69 | $16.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 151.9K | 105.4K |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | 5.89% | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $1.92 | N/A |
| Revenue Next Year | $0.67 | N/A |
| P/E Ratio | $25.52 | ★ $21.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.85 | $10.55 |
| 52 Week High | $25.85 | $17.80 |
| Indicator | MOV | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 55.96 |
| Support Level | $22.69 | $16.40 |
| Resistance Level | $25.53 | $17.40 |
| Average True Range (ATR) | 0.89 | 0.36 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 32.69 | 88.70 |
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.